Lauren M. Green
Articles
Moving Forward with PARP Inhibitors in Ovarian Cancer
July 13, 2017
Article
The treatment landscape of ovarian cancer continues to change with the recent approvals of new agents.
Clinical Trials are the Best Hope for Ovarian Cancer
July 12, 2017
Article
For women with ovarian cancer, the message is clear: participating in clinical trials, even early-phase ones, offers the best hope for better treatments, but efforts are urgently needed at every level to ensure that more of these research opportunities are available.
School of Nursing Oncology to Offer Comprehensive Update on New Treatments in One Meeting
June 19, 2017
Article
In August, Physician's Education Resource®, LLC will be sponsoring the 1st Annual School of Nursing OncologyTM (SONO) where nurses can earn 10.25 Contact Hours.
Easing Depression, Distress in Patients With Advanced Cancer Through Brief Therapy Sessions
June 08, 2017
Article
The novel psychological intervention, called CALM, has been shown to alleviate the distress of patients with advanced cancer.
Online Tool Allows Patients to Report Symptoms in Real Time, Improving Survival
June 04, 2017
Article
According to findings reported at ASCO 2017, patients receiving treatment for metastatic cancer who used a web-based tool to report their symptoms lived on average 5 months longer.
Lessons From the NICU: Nursing Support for Cancer Caregivers in the Hospital
May 19, 2017
Article
What kind of nursing interventions do grieving families want in the acute care setting? Answers may be found in the neonatal intensive care unit.
Eating Nuts May Reduce Recurrence Risk in Colon Cancer Survivors
May 18, 2017
Article
Eating tree nuts may improve overall survival and reduce the risk of recurrence in patients with colon cancer.
The Nose Knows: Using Aromatherapy to Relieve Symptoms in Patients Undergoing BMT
May 10, 2017
Article
A group of nurses at Froedtert Hospital developed a study to evaluate the use of aromatherapy to relieve symptoms in patients undergoing blood and marrow transplant.
FDA Approves Co-Packaging of Ribociclib With Letrozole to Treat MBC
May 10, 2017
Article
The FDA has approved the co-packaging of oral medication ribociclib and letrozole, used to treat HR-positive, HER2-negative advanced breast cancer in postmenopausal women.